Clinical and Haematologic Correlates of Soluble VCAM-1 in Adults With Steady-State Sickle Cell Disease.
7 affiliations
- 1Ghana Institute of Clinical Genetics Accra Ghana.
- 2Department of Haematology Korle-Bu Teaching Hospital Accra Ghana.
- 3College of Health Sciences University of Ghana Accra Ghana.
- 4Centre for Tropical Clinical Pharmacology and Therapeutics University of Ghana Medical School Accra Ghana.
- 5Department of Immunology Noguchi Memorial Institute for Medical Research Accra Ghana.
- 6Department of Haematology University of Ghana Medical School Accra Ghana.
- 7Vancouver Coastal Health Richmond Canada.
Abstract
Background
Endothelial activation contributes to the vasculopathy of sickle cell disease (SCD). We evaluated serum soluble vascular cell adhesion molecule-1 (sVCAM-1), a surrogate marker of endothelial activation, and examined its clinical and haematologic correlates in adults with steady-state SCD.Methods
This was a cross-sectional study of 75 adults with steady-state SCD (HbSS: 86.7%; HbSC: 13.3%) and 75 age-matched comparison participants with normal adult haemoglobin genotype (HbAA). Associations of clinical and haematologic measures with sVCAM-1 were evaluated using correlation and multivariable linear regression analyses.Results
SCD participants had lower systolic blood pressure (SBP), BMI and haemoglobin and elevated leukocyte, platelet, reticulocyte, total bilirubin and LDH levels, compared with HbAA participants (all p < 0.001). Mean sVCAM-1 was higher in SCD than in HbAA participants (878.8 vs. 507.9 ng/mL; p < 0.001), with no significant difference between HbSS and HbSC. In the combined SCD cohort, sVCAM-1 correlated positively with absolute reticulocyte count (r = 0.24, p = 0.034). In HbSS, sVCAM-1 correlated positively with SBP (r = 0.264, p = 0.033). In multivariable analysis, higher reticulocyte count (B = 73.39 ng/mL per 100x10⁹/L increase, p = 0.014) and lower BMI (B = -15.3, p = 0.038) were independently associated with higher sVCAM-1 in SCD. In HbSS, total bilirubin was inversely associated with sVCAM-1 in the primary model (B = -1.62, p = 0.041), although this association was attenuated in sensitivity analyses.Conclusion
Higher reticulocyte count was consistently associated with higher sVCAM-1 in adults with steady-state SCD. Associations of sVCAM-1 with BMI, bilirubin and SBP were also observed, but these genotype-specific findings warrant cautious interpretation, particularly given the small size of the HbSC subgroup. These findings support further prospective evaluation of clinical and haematologic correlates of endothelial activation in SCD.Trial registration
The authors have confirmed clinical trial registration is not needed for this submission.
Related
- Longitudinal trajectories of questionnaire-derived health burden and clinical correlates among community-dwelling older adults: a retrospective cohort study in Deyang, China
- Disease-Specific Clinical Correlates of Vitamin D in Systemic Lupus Erythematosus and Behçet’s Disease
- Clinical Correlates of Suicidal Ideation in Adults With Obsessive-Compulsive Disorder: An Interpretable Machine Learning Study
- Profiles of Cognitive Appraisal of Non-Suicidal Self-Injury Scars and Their Clinical Correlates in Adults with a History of Self-Injury: A Cross-Sectional Study.
- Soluble guanylate cyclase modulation in heart failure and chronic kidney disease: mechanisms, clinical evidence, and translational boundaries
BibTeX
@article{ghunney2026clinical,
title = {{Clinical and Haematologic Correlates of Soluble VCAM-1 in Adults With Steady-State Sickle Cell Disease.}},
author = {William Kwesi Ghunney and Eugenia Vicky Asare and John Benaiah Ayete-Nyampong and Wonder Doku-Agama and Eric Kyei-Baafour and Michael Fokou Ofori and George Obeng Adjei and Edeghonghon Olayemi},
journal = {EJHaem},
year = {2026},
month = oct,
doi = {10.1002/jha2.70413},
url = {https://europepmc.org/article/MED/42924294},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical and Haematologic Correlates of Soluble VCAM-1 in Adults With Steady-State Sickle Cell Disease.
AU - William Kwesi Ghunney
AU - Eugenia Vicky Asare
AU - John Benaiah Ayete-Nyampong
AU - Wonder Doku-Agama
AU - Eric Kyei-Baafour
AU - Michael Fokou Ofori
AU - George Obeng Adjei
AU - Edeghonghon Olayemi
PY - 2026
DA - 2026/10/22
JO - EJHaem
DO - 10.1002/jha2.70413
UR - https://europepmc.org/article/MED/42924294
AB - Background Endothelial activation contributes to the vasculopathy of sickle cell disease (SCD). We evaluated serum soluble vascular cell adhesion molecule-1 (sVCAM-1), a surrogate marker of endothelial activation, and examined its clinical and haematologic correlates in adults with steady-state SCD.Methods This was a cross-sectional study of 75 adults with steady-state SCD (HbSS: 86.7%; HbSC: 13.3%) and 75 age-matched comparison participants with normal adult haemoglobin genotype (HbAA). Associations of clinical and haematologic measures with sVCAM-1 were evaluated using correlation and multivariable linear regression analyses.Results SCD participants had lower systolic blood pressure (SBP), BMI and haemoglobin and elevated leukocyte, platelet, reticulocyte, total bilirubin and LDH levels, compared with HbAA participants (all p < 0.001). Mean sVCAM-1 was higher in SCD than in HbAA participants (878.8 vs. 507.9 ng/mL; p < 0.001), with no significant difference between HbSS and HbSC. In the combined SCD cohort, sVCAM-1 correlated positively with absolute reticulocyte count (r = 0.24, p = 0.034). In HbSS, sVCAM-1 correlated positively with SBP (r = 0.264, p = 0.033). In multivariable analysis, higher reticulocyte count (B = 73.39 ng/mL per 100x10⁹/L increase, p = 0.014) and lower BMI (B = -15.3, p = 0.038) were independently associated with higher sVCAM-1 in SCD. In HbSS, total bilirubin was inversely associated with sVCAM-1 in the primary model (B = -1.62, p = 0.041), although this association was attenuated in sensitivity analyses.Conclusion Higher reticulocyte count was consistently associated with higher sVCAM-1 in adults with steady-state SCD. Associations of sVCAM-1 with BMI, bilirubin and SBP were also observed, but these genotype-specific findings warrant cautious interpretation, particularly given the small size of the HbSC subgroup. These findings support further prospective evaluation of clinical and haematologic correlates of endothelial activation in SCD.Trial registration The authors have confirmed clinical trial registration is not needed for this submission.
SN - 2688-6146
ER -